Abivax (ABVX.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | |
| Operating Expenses | 35,325 | 44,671 |
| Operating Income | -35,325 | -44,671 |
| Interest Expense | 3,828 | 2,424 |
| Other Income | 383 | 4,228 |
| Pre-tax Income | -38,770 | -42,867 |
| Net Income Continuous | -38,770 | -42,867 |
| Net Income | $-38,771 | $-42,867 |
| EPS Basic Total Ops | -0.62 | -0.68 |
| EPS Basic Continuous Ops | -0.62 | -0.68 |
| EPS Diluted Total Ops | -0.62 | -0.68 |
| EPS Diluted Continuous Ops | -0.62 | -0.68 |
| EBITDA(a) | $-34,577 | $-40,232 |